Natera (NTRA) Shares Drop 5% as Executive Chairman Offloads $8.38M in Stock
Natera's stock fell sharply after Executive Chairman Matthew Rabinowitz sold 54,000 shares between May 15 and June 13, netting $8.38 million. The sales occurred at prices ranging from $150.20 to $165.85, leaving the stock NEAR its 52-week high of $183 despite the dip.
The genetic testing firm remains a top holding for billionaire Stanley Druckenmiller, with Rabinowitz retaining significant exposure through 2.36 million directly held shares worth $392.76 million at current prices. Natera's 54% annual gain reflects strong financial performance in its DNA-based cancer and organ health diagnostics business.